Skip to main content
Premium Trial:

Request an Annual Quote

Natera Prices $250M Senior Notes Offering

NEW YORK – Natera said on Tuesday that it has priced the $250 million convertible senior notes offering it had announced the day before.

The notes, which will be sold to qualified institutional buyers, will have an initial conversion rate of 25.7785 shares of common stock per $1,000 principal amount of notes, which represents an initial effective conversion price of about $38.79 per share, approximately a 30 percent premium to the $29.84 closing price of Natera's stock on Monday.

The initial buyers of the notes have been granted a 13-day option to purchase up to an additional $37.5 million aggregate principal amount of the notes.

As previously noted, Natera plans to use a portion of the net proceeds from the offering to repay its 2017 Term Loan with OrbiMed, and another part for working capital, general corporate purposes, and research and development. It may also use the proceeds to acquire complementary businesses, technologies, or other assets, though the firm said it has no agreements or understandings regarding material acquisitions or strategic transactions at this time.

The senior notes will pay 2.25 percent interest in cash per year on a semi-annual basis, starting Nov. 1, and will mature on May 1, 2027 unless redeemed, repurchased, or converted prior to this date.

The sale is expected to close on April 16.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.